IRICoR is very proud to announce the recipients of their 4th edition of Scholarship Competition – Entrepreneurship in Oncology (CEO).
This initiative offers the next generation of scientists an opportunity to take part in the Life Sciences Entrepreneurship Development Program initiated by a partnership between Montréal InVivo, the Faculté de pharmacie de l’Université […]

Montreal, February 11, 2021 – On this United Nations International Day of Women and Girls in Science, IRICoR is proud to honor all the great women who make up its team and to remind that women and girls play a role essential in the scientific community.
In addition, come and listen to 6 women, including our President and CEO, Nadine Beauger, […]

2019-2020, a prosperous year under the theme of growth
The year 2019-2020 took place under the theme of growth. The IRICoR solution has benefited to a growing number of national and international researchers. IRICoR is proud to present its activity report. To consult it, click on the image.

IRICoR is very pleased to announce the appointment as of January 11, 2021 of Rémi-Martin Laberge as Vice-President, Scientific Operations and new member of IRICoR’s Management team. In this role, Dr. Laberge’s responsibilities will include ensuring, with his team, a continued follow-up of portfolio projects with support to the research teams, and identification of new opportunities in line with a […]

IRICoR is proud to welcome Ms. Hélène Grangé to its team, as Senior Manager – Contracts and Licenses.
As part of IRICoR’s business development team, Ms. Grangé will play a key role in the development and management of contracts and licenses involving IRICoR and its numerous partners in the private and public sectors. She will interact with various stakeholders both internally […]

Investment will support clinical trial in sickle cell disease
MONTREAL, Aug. 7, 2020 /CNW Telbec/ – IRICoR, a Centre of Excellence in Commercialization and Research with a focus on drug discovery, announces a new investment in ExCellThera Inc., a clinical-stage cell and molecular medicine company which it co-founded in 2015.
IRICoR’s investment enabled ExCellThera to secure the co-funding required in connection with […]

$3M for new treatment research, a joint investment of IRICoR and the Quebec Breast Cancer Foundation
Montreal, July 14, 2020 – The pandemic has highlighted the importance of supporting scientific research in order to allow investigators to find real solutions to deal with public health issues such as COVID-19 or cancer. In this context, IRICoR and the Quebec Breast Cancer Foundation […]

During BIO Digital on June 11,  our CEO Nadine Beauger was a guest speaker at Connect with Canada, a webinar discussion with Minister Navdeep Bains (Minister of Innovation, Science and Industry),  Gordon McCauley (President and CEO AdMare BioInnovations) and Andrew Casey (CEO BIOTECanada).
The discussion explored Canadian innovation in the face of COVID-19, and the role Canada’s biotech industry will play […]

On June 11th, 2020 Nadine Beauger, President & CEO at IRICoR, will take part in a discussion session as a guest speaker at Connect with Canada presented by BIOTECanada. Along with The Honourable Minister Navdeep,Canada’s Minister of Innovation, Science and Industry, and Gordon McCauley from adMare BioInnovations, Nadine Beauger will discuss about Canada’s biotech ecosystem in the context of the […]

PARIS, France, and MONTREAL, Canada, 04 May 2020 — Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, IRICoR, a pan-Canadian drug discovery and research commercialization center, and Université de Montréal, today announced they entered into an option agreement by which Ipsen would acquire an exclusive license for the worldwide rights to a high-value oncology program.
Under the leadership of […]